Digital therapy firms link up with Swiss accelerator KickstartSeveral digital therapy and digital health firms have been selected to join a group of startups by the Share XDigital therapy firms link up with Swiss accelerator Kickstarthttps://pharmaphorum.com/news/digital-therapy-firms-link-up-with-swiss-accelerator-kickstart/
FDA approves Akili’s video game ADHD therapyThe FDA has approved the first video game-based treatment for attention deficit hyperactivity disorder (ADHD), from Akili. Called EndeavorRx, Share XFDA approves Akili’s video game ADHD therapyhttps://pharmaphorum.com/news/fda-approves-akilis-video-game-adhd-therapy/
COVID-19 gives Akili’s digital ADHD treatment an early debut in USAn app to treat children with attention-deficit hyperactivity disorder (ADHD) developed by Akili has been made available ahead Share XCOVID-19 gives Akili’s digital ADHD treatment an early debut in UShttps://pharmaphorum.com/news/covid-19-gives-akilis-digital-adhd-treatment-an-early-debut-in-us/
Personalising digital mental health treatmentIn the age of smartphones and virtual reality, NHS trusts must evolve their approach to reach patients, and Share XPersonalising digital mental health treatmenthttps://pharmaphorum.com/views-analysis-digital/personalising-digital-mental-health-treatment/
Digital therapeutics formularies five years away in US, say payersPayers from the US may not include digital therapeutics products on formularies for another five years, according to Share XDigital therapeutics formularies five years away in US, say payershttps://pharmaphorum.com/news/digital-therapeutics-formularies-five-years-away-in-us-say-payers/
Sanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticsPaul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk Share XSanofi’s Bozidar Jovicevic on how the company is approaching digital therapeuticshttps://pharmaphorum.com/video/sanofis-bozidar-jovicevic-on-how-the-company-is-approaching-digital-therapeutics/
UCB’s James Musick on embracing digital therapeuticsDigital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it. Share XUCB’s James Musick on embracing digital therapeuticshttps://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/
Digital therapeutics and their impact on societyIn the 20th century, research, technology and new novel treatments have enabled us to increase the average lifespan Share XDigital therapeutics and their impact on societyhttps://pharmaphorum.com/partner-content/digital-therapeutics-and-their-impact-on-society/
Sandoz says ‘no’ to Pear Therapeutics’ digital apps, handing back rightsNovartis has made no secret of its desire to become a leader in digital therapeutics (DTx), but that Share XSandoz says ‘no’ to Pear Therapeutics’ digital apps, handing back rightshttps://pharmaphorum.com/news/sandoz-says-no-to-pear-therapeutics-digital-app-handing-back-rights/
